The EANM practice guidelines for bone scintigraphy T Van den Wyngaert, K Strobel, WU Kampen, T Kuwert, ... European journal of nuclear medicine and molecular imaging 43, 1723-1738, 2016 | 407 | 2016 |
Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment O Nicolatou-Galitis, M Schiødt, RA Mendes, C Ripamonti, S Hope, ... Oral surgery, oral medicine, oral pathology and oral radiology 127 (2), 117-135, 2019 | 355 | 2019 |
Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases S Otto, C Pautke, T Van den Wyngaert, D Niepel, M Schiødt Cancer treatment reviews 69, 177-187, 2018 | 302 | 2018 |
Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy? T Van den Wyngaert, MT Huizing, JB Vermorken Annals of Oncology 17 (8), 1197-1204, 2006 | 191 | 2006 |
Maintenance fluid therapy and fluid creep impose more significant fluid, sodium, and chloride burdens than resuscitation fluids in critically ill patients: a retrospective … N Van Regenmortel, W Verbrugghe, E Roelant, T Van den Wyngaert, ... Intensive care medicine 44, 409-417, 2018 | 180 | 2018 |
Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome T Van den Wyngaert, T Claeys, MT Huizing, JB Vermorken, E Fossion Annals of Oncology 20 (2), 331-336, 2009 | 177 | 2009 |
18F-NaF PET/CT: EANM procedure guidelines for bone imaging M Beheshti, FM Mottaghy, F Payche, FFF Behrendt, T Van den Wyngaert, ... European journal of nuclear medicine and molecular imaging 42, 1767-1777, 2015 | 144 | 2015 |
Osteonecrosis of the jaw related to the use of bisphosphonates T Van den Wyngaert, MT Huizing, JB Vermorken Current opinion in oncology 19 (4), 315-322, 2007 | 117 | 2007 |
RapidArc, SmartArc and TomoHD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison D Van Gestel, C van Vliet-Vroegindeweij, F Van den Heuvel, W Crijns, ... Radiation Oncology 8, 1-12, 2013 | 91 | 2013 |
FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance N Helsen, T Van den Wyngaert, L Carp, S Stroobants European journal of nuclear medicine and molecular imaging 45, 1063-1071, 2018 | 79 | 2018 |
Molecular imaging of apoptosis: the case of caspase-3 radiotracers L Beroske, T Van den Wyngaert, S Stroobants, P Van der Veken, F Elvas International journal of molecular sciences 22 (8), 3948, 2021 | 72 | 2021 |
RANK ligand inhibition in bone metastatic cancer and risk of osteonecrosis of the jaw (ONJ): non bis in idem? T Van den Wyngaert, K Wouters, MT Huizing, JB Vermorken Supportive Care in Cancer 19, 2035-2040, 2011 | 71 | 2011 |
Effect of isotonic versus hypotonic maintenance fluid therapy on urine output, fluid balance, and electrolyte homeostasis: a crossover study in fasting adult volunteers N Van Regenmortel, T De Weerdt, AH Van Craenenbroeck, E Roelant, ... BJA: British Journal of Anaesthesia 118 (6), 892-900, 2017 | 70 | 2017 |
SPECT/CT: Standing on the shoulders of giants, it is time to reach for the sky! T Van den Wyngaert, F Elvas, S De Schepper, JA Kennedy, O Israel Journal of Nuclear Medicine 61 (9), 1284-1291, 2020 | 63 | 2020 |
Fluorodeoxyglucose-positron emission tomography/computed tomography after concurrent chemoradiotherapy in locally advanced head-and-neck squamous cell cancer: the ECLYPS study T Van den Wyngaert, N Helsen, L Carp, S Hakim, MJ Martens, I Hutsebaut, ... Journal of Clinical Oncology 35 (30), 3458-3464, 2017 | 62 | 2017 |
Impact of chloride and strong ion difference on ICU and hospital mortality in a mixed intensive care population N Van Regenmortel, W Verbrugghe, T Van den Wyngaert, PG Jorens Annals of Intensive Care 6, 1-9, 2016 | 61 | 2016 |
EANM practice guideline for quantitative SPECT-CT JC Dickson, IS Armstrong, PM Gabiña, AM Denis-Bacelar, AK Krizsan, ... European journal of nuclear medicine and molecular imaging 50 (4), 980-995, 2023 | 52 | 2023 |
Bisphosphonates in oncology: rising stars or fallen heroes T Van den Wyngaert, MT Huizing, E Fossion, JB Vermorken The oncologist 14 (2), 181-191, 2009 | 49 | 2009 |
Neoadjuvant systemic therapy in breast cancer: Challenges and uncertainties M Van de Wiel, Y Dockx, T Van den Wyngaert, S Stroobants, WAA Tjalma, ... European Journal of Obstetrics & Gynecology and Reproductive Biology 210 …, 2017 | 48 | 2017 |
154 compared to 54 mmol per liter of sodium in intravenous maintenance fluid therapy for adult patients undergoing major thoracic surgery (TOPMAST): a single-center randomized … N Van Regenmortel, S Hendrickx, E Roelant, I Baar, K Dams, ... Intensive Care Medicine 45, 1422-1432, 2019 | 47 | 2019 |